Non-Antibody Products — page 88 of 94
Non-Antibody Products
Page 88 of 94
| Name | Description | Size | Catalog # | Supplier | |
|---|---|---|---|---|---|
| Azvudine | of lung ground-glass opacities observed via chest X-ray in a rhesus macaq… | 10 mg | 37669-10 |
 CAYMAN CHEMICAL COMPANY |
More Info |
| Azvudine | of lung ground-glass opacities observed via chest X-ray in a rhesus macaq… | 25 mg | 37669-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Azvudine | of lung ground-glass opacities observed via chest X-ray in a rhesus macaq… | 5 mg | 37669-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Azvudine | of lung ground-glass opacities observed via chest X-ray in a rhesus macaq… | 50 mg | 37669-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| STING Agonist 23 | replication of HSV, RRV, and SARS-CoV-2 in vitro (EC50s… | 10 mg | 38345-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| STING Agonist 23 | replication of HSV, RRV, and SARS-CoV-2 in vitro (EC50s… | 25 mg | 38345-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| STING Agonist 23 | replication of HSV, RRV, and SARS-CoV-2 in vitro (EC50s… | 5 mg | 38345-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| HY-17542 | A SARS-CoV PLpro inhibitor (IC50 = 2.6 µM); increa… | 1 mg | 33354-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| HY-17542 | A SARS-CoV PLpro inhibitor (IC50 = 2.6 µM); increa… | 10 mg | 33354-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| HY-17542 | A SARS-CoV PLpro inhibitor (IC50 = 2.6 µM); increa… | 25 mg | 33354-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| HY-17542 | A SARS-CoV PLpro inhibitor (IC50 = 2.6 µM); increa… | 5 mg | 33354-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Recombinant Bat coronavirus 133/2005 Spike glycoprotein (S), partial | coronavirus 133 / 2005 (BtCoV) (BtCoV/133 / 2005). Targ… | 20ug, 100ug, 1mg | RPC27965 |
 BIOMATIK |
More Info |
| PAMAM Dendrimer G2.0 Succinamic Acid (water solution) | induced by MERS-CoV in Vero cells at 10 µM | 1 g | 39119-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| PAMAM Dendrimer G2.0 Succinamic Acid (water solution) | induced by MERS-CoV in Vero cells at 10 µM | 500 mg | 39119-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
| UBE2G1 shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-93745-V |
 SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| BIOTIN-PEG4-SBP1(spike-binding peptide 1) | SARS-CoV-2 spike protein. SBP1 specifically binds SARS-… | 5 mg | orb654591 |
 BIORBYT LTD. |
More Info |
| P504S shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-92063-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| IC-8 | formation of lipid nanoparticles (LNPs). Immunization with severe acute r… | 100 mg, 25 mg | orb1785882 |
BIORBYT LTD. |
More Info |
| Plitidepsin | inflammation in the K18-hACE2 mouse model of SARS-CoV-<… | 1 mg | 34053-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Plitidepsin | inflammation in the K18-hACE2 mouse model of SARS-CoV-<… | 500 µg | 34053-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
| ACSVL1 shRNA (mouse) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-140837-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| TSCOT shRNA (mouse) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-154712-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| CD8-alpha shRNA (h2) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-35028-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| COL11A2 shRNA (mouse) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-142459-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| HscB shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-75306-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| Fludarabine | inhibitor of SARS-CoV-2 RdRp (EC50 = 1.06 µM); co… | 10 mg | 14128-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Fludarabine | inhibitor of SARS-CoV-2 RdRp (EC50 = 1.06 µM); co… | 25 mg | 14128-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Fludarabine | inhibitor of SARS-CoV-2 RdRp (EC50 = 1.06 µM); co… | 5 mg | 14128-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Fludarabine | inhibitor of SARS-CoV-2 RdRp (EC50 = 1.06 µM); co… | 50 mg | 14128-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Efonidipine | infarction induced by ligation of the left coronary artery at 200 mg / kg… | 10 mg | 33114-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Efonidipine | infarction induced by ligation of the left coronary artery at 200 mg / kg… | 100 mg | 33114-100 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Efonidipine | infarction induced by ligation of the left coronary artery at 200 mg / kg… | 5 mg | 33114-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Efonidipine | infarction induced by ligation of the left coronary artery at 200 mg / kg… | 50 mg | 33114-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Virus-URP6 Multiplexed RT-qPCR Assay | (Influenza A), HEX (RPP30), TexasRED615 (SARS-CoV2) | 1 ea | 40701-10020 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Nitazoxanide | against M. tuberculosis and M. bovis (MIC = 16 µg / ml for both); i… | 10 mg | 13692-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Nitazoxanide | against M. tuberculosis and M. bovis (MIC = 16 µg / ml for both); i… | 100 mg | 13692-100 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Nitazoxanide | against M. tuberculosis and M. bovis (MIC = 16 µg / ml for both); i… | 250 mg | 13692-250 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Nitazoxanide | against M. tuberculosis and M. bovis (MIC = 16 µg / ml for both); i… | 50 mg | 13692-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Ac-Leu-Leu-Methional (ALLM) | Coronavirus inhibitor: Inhibits key SARS-CoV-2 protease… | 5 mg, 25 mg, | abx282261 |
 ABBEXA LTD |
More Info |
| LPCAT1 shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-91777-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| ACSVL1 shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-90127-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| Human IL-7 R alpha&TSLP R Heterodimer Protein, Fc Tag&Fc Tag (MALS verified) | 16871-1 (I66T, V138I) (IL-7RA) & Q9HC73-1 (TSLPR)). Human IL-7 RA… | 100ug | ILR-H5255-100ug |
 ACROBIOSYSTEMS USA |
More Info |
| Human IL-7 R alpha&TSLP R Heterodimer Protein, Fc Tag&Fc Tag (MALS verified) | 16871-1 (I66T, V138I) (IL-7RA) & Q9HC73-1 (TSLPR)). Human IL-7 RA… | 1mg | ILR-H5255-1mg |
ACROBIOSYSTEMS USA |
More Info |
| Recombinant Mycobacterium tuberculosis Diacylglycerol acyltransferase/mycolyltransferase Ag85A (fbpA), partial | ) formation with long-chain acyl-CoA as. MW: 34.2kD | 0.01 mg, 0.05 mg, 0.1 mg | MBS1265459 |
 MYBIOSOURCE INC. |
More Info |
| alpha-KGD shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-60105-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| Recombinant Bat coronavirus HKU9 Spike glycoprotein (S), partial | ) (BtCoV/HKU9). Target Name: S. Target Synonyms: S glycoprotein;… | 20ug, 100ug, 1mg | RPC28019 |
BIOMATIK |
More Info |
| diABZI STING Agonist-1 (hydrochloride) | the cytopathic effect of HCoV-229E in infected MRC-5 cells (EC50… | 1 mg | 28054-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| diABZI STING Agonist-1 (hydrochloride) | the cytopathic effect of HCoV-229E in infected MRC-5 cells (EC50… | 5 mg | 28054-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| diABZI STING Agonist-1 (hydrochloride) | the cytopathic effect of HCoV-229E in infected MRC-5 cells (EC50… | 500 µg | 28054-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Virus-URP7 COVID, Flu AB, RSV AB, RPP30 4-color Multiplexed RT-qPCR Assay | (Influenza A and B), HEX (RPP30), TexasRED615 (SARS-CoV2
| 1 ea |
40704-10020 |
|
CAYMAN CHEMICAL COMPANY
More Info
|
|